These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. Cafaggi S; Russo E; Stefani R; Leardi R; Caviglioli G; Parodi B; Bignardi G; De Totero D; Aiello C; Viale M J Control Release; 2007 Aug; 121(1-2):110-23. PubMed ID: 17601625 [TBL] [Abstract][Full Text] [Related]
5. Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug. Wang W; Chen S; Zhang L; Wu X; Wang J; Chen JF; Le Y Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():514-20. PubMed ID: 25492016 [TBL] [Abstract][Full Text] [Related]
6. Vaccination of horses against strangles using recombinant antigens from Streptococcus equi. Waller A; Flock M; Smith K; Robinson C; Mitchell Z; Karlström A; Lannergård J; Bergman R; Guss B; Flock JI Vaccine; 2007 May; 25(18):3629-35. PubMed ID: 17321016 [TBL] [Abstract][Full Text] [Related]
7. Preparation and properties of a pH sensitive carrier based on three kinds of polymer blend to control the release of 5-amino salicylic acid. Dong Y; Zhou Z; Ding H; Zhang S Pharm Dev Technol; 2014 Dec; 19(8):960-7. PubMed ID: 24320757 [TBL] [Abstract][Full Text] [Related]
8. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles. Essa S; Rabanel JM; Hildgen P Int J Pharm; 2010 Mar; 388(1-2):263-73. PubMed ID: 20060450 [TBL] [Abstract][Full Text] [Related]
9. New approach on the development of a mucosal vaccine against strangles: Systemic and mucosal immune responses in a mouse model. Florindo HF; Pandit S; Gonçalves LM; Alpar HO; Almeida AJ Vaccine; 2009 Feb; 27(8):1230-41. PubMed ID: 19114079 [TBL] [Abstract][Full Text] [Related]
10. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers. Chen F; Zhang ZR; Huang Y Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144 [TBL] [Abstract][Full Text] [Related]
11. In vitro hemocompatibility of PVA-alginate ester as a candidate for hemodialysis membrane. Amri C; Mudasir M; Siswanta D; Roto R Int J Biol Macromol; 2016 Jan; 82():48-53. PubMed ID: 26459169 [TBL] [Abstract][Full Text] [Related]
12. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
13. Alginate/chitosan nanoparticles for encapsulation and controlled release of vitamin B2. Azevedo MA; Bourbon AI; Vicente AA; Cerqueira MA Int J Biol Macromol; 2014 Nov; 71():141-6. PubMed ID: 24863916 [TBL] [Abstract][Full Text] [Related]
14. A therapeutic polyelectrolyte-vitamin C nanoparticulate system in polyvinyl alcohol-alginate hydrogel: An approach to treat skin and soft tissue infections caused by Staphylococcus aureus. George L; Bavya MC; Rohan KV; Srivastava R Colloids Surf B Biointerfaces; 2017 Dec; 160():315-324. PubMed ID: 28950196 [TBL] [Abstract][Full Text] [Related]
15. Influence of the preparation methods on the drug release behaviour of loperamide-loaded nanoparticles. Ueda M; Iwara A; Kreuter J J Microencapsul; 1998; 15(3):361-72. PubMed ID: 9608398 [TBL] [Abstract][Full Text] [Related]
16. Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde. Tahtat D; Mahlous M; Benamer S; Khodja AN; Oussedik-Oumehdi H; Laraba-Djebari F Int J Biol Macromol; 2013 Jul; 58():160-8. PubMed ID: 23567292 [TBL] [Abstract][Full Text] [Related]
17. Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses. Flock M; Jacobsson K; Frykberg L; Hirst TR; Franklin A; Guss B; Flock JI Infect Immun; 2004 Jun; 72(6):3228-36. PubMed ID: 15155624 [TBL] [Abstract][Full Text] [Related]
18. Microparticulate poly(vinyl alcohol) hydrogel formulations for embedding and controlled release of polyethylenimine (PEI)-based nanoparticles. Schulze J; Hendrikx S; Schulz-Siegmund M; Aigner A Acta Biomater; 2016 Nov; 45():210-222. PubMed ID: 27592816 [TBL] [Abstract][Full Text] [Related]
19. VEGF-controlled release within a bone defect from alginate/chitosan/PLA-H scaffolds. De la Riva B; Nowak C; Sánchez E; Hernández A; Schulz-Siegmund M; Pec MK; Delgado A; Evora C Eur J Pharm Biopharm; 2009 Sep; 73(1):50-8. PubMed ID: 19442724 [TBL] [Abstract][Full Text] [Related]
20. Quaternized chitosan-organic rectorite intercalated composites based nanoparticles for protein controlled release. Xu R; Xin S; Zhou X; Li W; Cao F; Feng X; Deng H Int J Pharm; 2012 Nov; 438(1-2):258-65. PubMed ID: 22982258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]